China National Medicines Corporation Statistics
Total Valuation
China National Medicines Corporation has a market cap or net worth of CNY 25.97 billion. The enterprise value is 20.18 billion.
Market Cap | 25.97B |
Enterprise Value | 20.18B |
Important Dates
The last earnings date was Monday, October 21, 2024.
Earnings Date | Oct 21, 2024 |
Ex-Dividend Date | Jun 13, 2024 |
Share Statistics
China National Medicines Corporation has 754.50 million shares outstanding. The number of shares has increased by 0.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 754.50M |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 10.62% |
Float | 324.11M |
Valuation Ratios
The trailing PE ratio is 12.00 and the forward PE ratio is 10.77.
PE Ratio | 12.00 |
Forward PE | 10.77 |
PS Ratio | 0.51 |
PB Ratio | 1.56 |
P/TBV Ratio | n/a |
P/FCF Ratio | 16.87 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.09, with an EV/FCF ratio of 13.11.
EV / Earnings | 9.32 |
EV / Sales | 0.39 |
EV / EBITDA | 8.09 |
EV / EBIT | 8.77 |
EV / FCF | 13.11 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.04.
Current Ratio | 2.04 |
Quick Ratio | 1.66 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.27 |
Debt / FCF | 0.43 |
Interest Coverage | 111.26 |
Financial Efficiency
Return on equity (ROE) is 13.20% and return on invested capital (ROIC) is 7.91%.
Return on Equity (ROE) | 13.20% |
Return on Assets (ROA) | 4.36% |
Return on Capital (ROIC) | 7.91% |
Revenue Per Employee | 16.31M |
Profits Per Employee | 689,922 |
Employee Count | 3,138 |
Asset Turnover | 1.55 |
Inventory Turnover | 9.91 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.27% in the last 52 weeks. The beta is 0.45, so China National Medicines Corporation's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | +21.27% |
50-Day Moving Average | 31.18 |
200-Day Moving Average | 32.11 |
Relative Strength Index (RSI) | 63.60 |
Average Volume (20 Days) | 8,702,335 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, China National Medicines Corporation had revenue of CNY 51.19 billion and earned 2.16 billion in profits. Earnings per share was 2.87.
Revenue | 51.19B |
Gross Profit | 3.83B |
Operating Income | 2.30B |
Pretax Income | 2.91B |
Net Income | 2.16B |
EBITDA | 2.41B |
EBIT | 2.30B |
Earnings Per Share (EPS) | 2.87 |
Balance Sheet
The company has 8.30 billion in cash and 664.61 million in debt, giving a net cash position of 7.63 billion or 10.12 per share.
Cash & Cash Equivalents | 8.30B |
Total Debt | 664.61M |
Net Cash | 7.63B |
Net Cash Per Share | 10.12 |
Equity (Book Value) | 18.46B |
Book Value Per Share | 22.01 |
Working Capital | 15.15B |
Cash Flow
In the last 12 months, operating cash flow was 1.69 billion and capital expenditures -147.92 million, giving a free cash flow of 1.54 billion.
Operating Cash Flow | 1.69B |
Capital Expenditures | -147.92M |
Free Cash Flow | 1.54B |
FCF Per Share | 2.04 |
Margins
Gross margin is 7.49%, with operating and profit margins of 4.49% and 4.23%.
Gross Margin | 7.49% |
Operating Margin | 4.49% |
Pretax Margin | 5.69% |
Profit Margin | 4.23% |
EBITDA Margin | 4.70% |
EBIT Margin | 4.49% |
FCF Margin | 3.01% |
Dividends & Yields
This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 2.43%.
Dividend Per Share | 0.85 |
Dividend Yield | 2.43% |
Dividend Growth (YoY) | 9.21% |
Years of Dividend Growth | 2 |
Payout Ratio | 34.70% |
Buyback Yield | -0.00% |
Shareholder Yield | 2.43% |
Earnings Yield | 8.34% |
FCF Yield | 5.93% |
Stock Splits
The last stock split was on June 3, 2009. It was a forward split with a ratio of 2.
Last Split Date | Jun 3, 2009 |
Split Type | Forward |
Split Ratio | 2 |
Scores
China National Medicines Corporation has an Altman Z-Score of 3.68.
Altman Z-Score | 3.68 |
Piotroski F-Score | n/a |